BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Foundation Medicine, Inc. 

One Kendall Square
Suite B3501
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-418-2200 Fax: 617-418-2201


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Roche (RHHBY) Extends Tender Offer For Foundation Medicine, Inc. (FMI) 3/2/2015 9:28:22 AM
Foundation Medicine, Inc. (FMI) Announces 2014 Fourth Quarter And Year-End Results, Recent Highlights And 2015 Outlook 2/25/2015 2:29:14 PM
Foundation Medicine, Inc. (FMI) And H3 Biomedicine Inc. Announce Collaboration To Develop Precision Therapies For Cancer 2/23/2015 11:38:50 AM
Foundation Medicine, Inc. (FMI) To Present New Clinical Data On Clinical Applications Of Foundationone At The 16th Annual Advances In Genome Biology And Technology Meeting 2/19/2015 12:22:42 PM
Roche (RHHBY) Commences Tender Offer For Up To 15,604,288 Shares Of Foundation Medicine, Inc. (FMI) For $50.00 Per Share In Cash 2/3/2015 9:40:57 AM
Roche (RHHBY) Pays $1.03 Billion for Majority Stake in Foundation Medicine, Inc. (FMI) 1/12/2015 5:46:37 AM
Foundation Medicine, Inc. (FMI) Release: FoundationOne® Identifies High Frequency Of Clinically Relevant Genomic Alterations (GA) Previously Missed By Conventional Genomic Tests, Enabling Successful Targeted Treatment In Patients With Non-Small Cell Lung Cancer 1/9/2015 10:41:36 AM
Foundation Medicine, Inc. (FMI) And Collaborators To Present New Clinical Data On The Application Of FoundationOne® At The 2015 Gastrointestinal Cancers Symposium 1/8/2015 10:39:50 AM
Foundation Medicine, Inc. (FMI) To Be Added To NASDAQ Biotechnology Index 12/16/2014 10:40:29 AM
Foundation Medicine, Inc. (FMI) Release: Treatment For Relapsed Multiple Myeloma Patients Guided By Foundationone® Heme Results In Promising Clinical Activity 12/8/2014 12:14:47 PM
123456